<DOC>
	<DOCNO>NCT01288872</DOCNO>
	<brief_summary>The purpose study understand whether drug praziquantel ( PZQ ) metabolize break differently woman pregnant versus pregnant . PZQ use treat schistosomiasis ( worm infection ) . Researchers study PZQ break among 15 woman 12-16 week pregnant , 15 woman 30-36 week pregnant , 15 woman nonpregnant woman produce breast milk . All woman 18 old otherwise healthy . The usual practice wait mother finish pregnancy breast feed give PZQ . Participants receive 2 dos PZQ separate 3 hour . Study procedures include 24 hour hospital stay follow administration PZQ , blood , stool urine sample , ultrasound pregnant , physical exam mother baby . Patient participation mother/infant pair 9 month .</brief_summary>
	<brief_title>Praziquantel-Pharmacokinetic Study</brief_title>
	<detailed_description>Schistosomiasis infect 200 million individual remain significant cause morbidity mortality develop country , despite availability effective pharmacologic therapy praziquantel ( PZQ ) . Researchers propose conduct phase I study pharmacokinetics ( PK ) safety PZQ treatment Schistosomiasis ( S. ) japonicum among pregnant lactate woman live province Leyte , The Philippines . In practice , treatment schistosomiasis withhold pregnant lactate post partum woman Philippines well country endemic schistosomiasis . Without treatment , woman accrue know morbidity identify among non-pregnant subject include hepatic fibrosis , under-nutrition , anemia . The overall aim study see difference PZQ PK safety pregnancy compare post partum , describe kinetics breast milk transfer PZQ estimate dose PZQ receive nursing infant whose mother treat PZQ . This protocol enroll 15 pregnant woman early pregnancy ( 12-16 week gestation ) , 15 pregnant woman late pregnancy ( 30-36 week gestation ) 15 lactate nonpregnant woman 5 7 month postpartum . The study population consist S. japonicum infect woman study village Municipal Health Centers . Women must : age 18 old , otherwise healthy without disease major organ system , without history seizure , chronic medical problem neurologic disorder , without history severe allergic reaction PZQ willing provide inform consent participate . The pregnant woman must : singleton pregnancy , carry fetus without evidence anomaly ultrasound . Pregnant subject treat PZQ early pregnancy ( 12-16 week gestation ) late pregnancy ( 30-36 week gestation ) , lactate nonpregnant ( 5-7 month postpartum inclusive ) . A total dose 60 mg/kg study medication provide 2 split dose 3 hour show substantially reduce drug side effect . All subject hospitalize overnight intensive blood sample monitor adverse event . Serial breast milk sample collect lactate woman . Plasma breast milk assay PZQ concentration . PK parameter pregnant postpartum woman compare kinetics praziquantel breast milk transfer estimation infant PZQ dose breast milk determine . Safety assessment perform pregnant woman infant 1 month postpartum , postpartum woman 2 week post dosing . This study link Division Microbiology Infectious Disease ( DMID ) protocol 06-0039 .</detailed_description>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Screening : Woman must age 18 . Present study midwife health center . Live study village . Inclusion criterion study follow : Infected Schistosomiasis ( S. ) japonicum . Age 18 old . Participant otherwise healthy determine history , physical exam , ultrasound ( pregnant ) laboratory assessment , exception laboratory value cite Exclusion Criteria . Early pregnancy cohort : pregnant , 1216 week gestation . Late pregnancy cohort : pregnant , 3036 week gestation Lactating nonpregnant : 57 month postpartum inclusive ( 7 month 31 day ) negative pregnancy test . Ability provide inform consent participate . Presence significant disease/illness either acute chronic . This defined history , physical examination , ultrasound ( pregnant ) laboratory assessment . In particular : 1 . History seizures neurologic disorder , chronic medical problem determine history physical examination , e.g. , active hepatitis , renal disease , tuberculosis , heart disease . 2 . Grade 3 high laboratory abnormality blood urea nitrogen ( BUN ) , creatinine , bilirubin , white blood cell count , platelet count warrant exclusion . Grade 2 high abnormality alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) warrant exclusion . For hemoglobin , woman severe anemia define hemoglobin less 7.0 g/dL exclude . 3 . If pregnant , myoma ultrasound submucosal OR woman myoma location great 5 cm size . 4 . If pregnant , congenital anomaly reproductive tract would expect cause decrease fetal weight greatly increase risk prematurity duplicate uterus , uterine septum . 5 . For less clear case , define significant illness one significantly alter woman 's ability perform activity daily live , cause symptom least two day per week , necessitate regular use medication . In case acute medical condition , urinary tract infection , pneumonia , febrile illness , enrollment may postpone illness successfully treat ( currently medication illness ) . For lactate postpartum subject : milk supply suspect marginal 24 hour interruption nursing likely lead inability restart breast feeding , evidence breast infection , history breast surgery . Presence cyst eye suggestive neurocysticercosis . Regular use medication chronic medical condition . History severe allergic reaction ( anaphylaxis , facial swelling , difficulty breathe ) seizure praziquantel administration . If pregnant , fetus congenital anomaly determine ultrasound determine nonviable e.g. , blight ovum . Twin high order pregnancy . Woman enrol study companion study ( `` S. japonicum pregnancy outcome : A Randomized , Double Blind , Placebo Controlled Trial ( RCT ) . DMID Protocol Number : 060039 '' ) previous pregnancy . Inability comprehend study procedure provide inform consent due limit cognitive ability reason , refuse provide inform consent . Subjects receive previous month follow drug may interact praziquantel ( PZQ ) bioavailability , metabolism and/or elimination : carbamazepine , chloroquine , cimetidine , dexamethasone , erythromycin , fosphenytoin , itraconazole , ketoconazole , phenobarbital , phenytoin , rifampin , protease inhibitor nonnucleoside reverse transcriptase inhibitor . Subjects ingest grapefruit juice previous week .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Praziquantal , Schistosomiasis , pregnant woman , Philippines</keyword>
</DOC>